Treatment Patterns and Use of Resources in Patients with Tuberous Sclerosis Complex: Insights from the TOSCA Registry

Ruben Marques,Elena Belousoye,Mirjana P. Benedik,Tom Carter,Vincent Cottin,Paolo Curatolo,Maria Dahlin,Lisa D'Amato,Guillaume Beaure d'Augeres,Petrus J. de Vries,Jose C. Ferreira,Martha Feucht,Carla Fladrowski,Christoph Hertzberg,Sergiusz Jozwiak,John A. Lawson,Alfons Macaya,Rima Nabbout,Finbar O'Callaghan,Jiong Qin,Valentin Sander,Matthias Sauter,Seema Shah,Yukitoshi Takahashi,Renaud Touraine,Sotiris Youroukos,Bernard Zonnenberg,John C. Kingswood,Anna C. Jansen,Nobuo Shinohara,Shigeo LIorie,Masaya Kubota,Jun Tohyama,Katsumi Imai,Mari Kaneda,Hideo Kaneko,Yasushi Uchida,Tomoko Kirino,Shoichi Endo,Yoshikazu Inoue,Katsuhisa Uruno,Ayse Serdaroglu,Zuhal Yapici,Banu Anlar,Sakir Altunbasak,Olga Lvova,Oleg Valeryevich Belyaev,Oleg Agranovich,Elena Vladislavovna Levitina,Yulia Vladimirovna Maksimova,Antonina Karas,Yuwu Jiang,Liping Zou,Kaifeng Xu,Yushi Zhang,Guoming Luan,Yuqin Zhang,Yi Wang,Meiling Jin,Dingwei Ye,Weiping Liao,Liemin Zhou,Jie Liu,Jianxiang Liao,Bo Yan,Yanchun Deng,Li Jiang,Zhisheng Liu,Shaoping Huang,Hua Li,Kijoong Kim,Pei-Lung Chen,Hsiu-Fen Lee,Jeng-Dau Tsai,Ching-Shiang Chi,Chao-Ching Huang,Australia Kate Riney,Deborah Yates,Patrick Kwan,Surachai Likasitwattanakul,Charcrin Nabangchang,Lunliya Thampratankul Krisnachai Chomtho,Kamornwan Katanyuwong,Somjit Sriudomkajorn,Jo Wilmshurst,Reeval Segel,Tal Gilboa,Michal Tzadok,Aviva Fattal-Valevski,Panagiotis Papathanasopoulos,Antigone Syrigou Papavasiliou,Stylianos Giannakodimos,Stylianos Gatzonis,Evangelos Pavlou,Meropi Tzoufi,A. M. M. Vergeer,Marc Dhooghe,Helene Verhelst,Filip Roelens,Marie Cecile Nassogne,Pierre Defresne,Liesbeth De Waele,Patricia Leroy,Nathalie Demonceau,Benjamin Legros,Patrick Van Bogaert,Berten Ceulemans,Lina Dom,Pierre Castelnau,Anne De Saint Martin,Audrey Riquet,Mathieu Milh,Claude Cances,Jean-Michel Pedespan,Dorothee Ville,Agathe Roubertie,Stephane Auvin,Patrick Berquin,Christian Richelme,Catherine Allaire,Sophie Gueden,Sylvie Nguyen The Tich,Bertrand Godet,Maria Luz Ruiz Falco Rojas,Jaume Campistol Planas,Antonio Martinez Bermejo,Patricia Smeyers Dura,Susana Roldan Aparicio,Maria Jesus Martinez Gonzalez,Javier Lopez Pison,Manuel Oscar Blanco Barca,Eduardo Lopez Laso,Olga Alonso Luengo,Francisco Javier Aguirre Rodriguez,Ignacio Malaga Dieguez,Ana Camacho Salas,Itxaso Marti Carrera,Eduardo Martinez Salcedo,Maria Eugenia Yoldi Petri,Ramon Cancho Candela,Ines da Conceicao Carrilho,Jose Pedro Vieira,Jose Paulo da Silva Oliveira Monteiro,Miguel Jorge Santos de Oliveira Ferreira Leao,Catarina Sofia Marceano Ribeiro Luis,Carla Pires Mendonca,Milda Endziniene,Jurgis Strautmanis,Inga Talvik,Maria Paola Canevini,Antonio Gambardella,Dario Pruna,Salvatore Buono,Elena Fontana,Bernardo Dalla Bernardina,Carmen Burloiu,Iuliu Stefan Bacos Cosma,Mihaela Adela Vintan,Laura Popescu,Karel Zitterbart,Jaroslava Payerova,Ladislav Bratsky,Zuzana Zilinska,Ursula Gruber-Sedlmayr,Matthias Baumann,Edda Laberlandt,Kevin Rostasy,Ekaterina Pataraia,Frances Elmslie,Clare Ann Johnston,Pamela Crawford,Peter Uldall,Paul Uvebrant,Olof Rask,Marit Bjoernvold,Eylert Brodtkorb,Andreas Sloerdahi,Ragnar Solhoff,Martine Sofie Gilje Jaatun,Marek Mandera,Elzbieta Janina Radzikowska,Mariusz Wysocki,Michael Fischereder,Gerhard Kurlemann,Bernd Wilken,Adelheid Wiemer-Kruel,Klemens Budde,Klaus Marquard,Markus Knuf,Andreas Hahn,Hans Hartmann,Andreas Merkenschlager,Regina Trollmann
DOI: https://doi.org/10.3389/fneur.2019.01144
IF: 3.4
2019-01-01
Frontiers in Neurology
Abstract:Tuberous Sclerosis Complex (TSC) is a rare autosomal-dominant disorder caused by mutations in the TSC1 or TSC2 genes. Patients with TSC may suffer from a wide range of clinical manifestations; however, the burden of TSC and its impact on healthcare resources needed for its management remain unknown. Besides, the use of resources might vary across countries depending on the country-specific clinical practice. The aim of this paper is to describe the use of TSC-related resources and treatment patterns within the TOSCA registry. A total of 2,214 patients with TSC from 31 countries were enrolled and had a follow-up of up to 5 years. A search was conducted to identify the variables containing both medical and non-medical resource use information within TOSCA. This search was performed both at the level of the core project as well as at the level of the research projects on epilepsy, subependymal giant cell astrocytoma (SEGA), lymphangioleiomyomatosis (LAM), and renal angiomyolipoma (rAML) taking into account the timepoints of the study, age groups, and countries. Data from the quality of life (QoL) research project were analyzed by type of visit and age at enrollment. Treatments varied greatly depending on the clinical manifestation, timepoint in the study, and age groups. GAB Aergics were the most prescribed drugs for epilepsy, and mTOR inhibitors are dramatically replacing surgery in patients with SEGA, despite current recommendations proposing both treatment options. mTOR inhibitors are also becoming common treatments in rAML and LAM patients. Forty-two out of the 143 patients (29.4%) who participated in the QoL research project reported inpatient stays over the last year. Data from non-medical resource use showed the critical impact of TSC on job status and capacity. Disability allowances were more common in children than adults (51.1% vs 38.2%). Psychological counseling, social services and social worker services were needed by <15% of the patients, regardless of age. The long-term nature, together with the variability in its clinical manifestations, makes TSC a complex and resource-demanding disease. The present study shows a comprehensive picture of the resource use implications of TSC.
What problem does this paper attempt to address?